| Assay ID | Title | Year | Journal | Article |
|---|
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID459066 | Inhibition of IAP by analogous luminescence assay | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID113962 | Anticonvulsant activity by the maximal electroshock test in mice by intraperitoneal administration | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles. |
| AID459068 | Inhibition of GCAP by analogous luminescence assay | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID459070 | Selectivity ratio of IC50 for GCAP to IC50 for PLAP | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID117081 | Lethal dose in mice determined after intraperitoneal administration. | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles. |
| AID459071 | Selectivity ratio of IC50 for TNAP to IC50 for PLAP | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID113963 | Anticonvulsant activity was evaluated by the maximal electroshock test in mice, administered orally | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles. |
| AID459069 | Selectivity ratio of IC50 for IAP to IC50 for PLAP | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID459065 | Inhibition of TNAP by analogous luminescence assay | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| AID459064 | Inhibition of PLAP by analogous luminescence assay | 2010 | Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
| Design and synthesis of selective inhibitors of placental alkaline phosphatase. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |